Arthneeti
Rainbow Child.Q4 FY23

Rainbow Child. Q4 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,457P/E: 51.2Market Cap: ₹14.7K CrSector: Healthcare Services

Management growth scorecard

Revenue

N/A

Margin

N/A

Fundraise

N/A

Order

N/A

Capex

N/A

0 of 0 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

No information is provided regarding the same in the latest conference call.

See what Rainbow Child. management said on margin guidance — free account, 30 seconds.

Fundraise plans

No information is provided regarding the same in the latest conference call.

See what Rainbow Child. management said on order book — free account, 30 seconds.

Capex plans

No information is provided regarding the same in the latest conference call.

Track Rainbow Child. — get its next earnings analysis in your feed

Margin guidance

No information is provided regarding the same in the latest conference call.

Order book

No information is provided regarding the same in the latest conference call.

How does Rainbow Child. rank vs peers in Healthcare Services?

Pro feature
ThisRainbow Child.
See where Rainbow Child. sits in Healthcare ServicesSee which companies these are, and every other name in the sector.Open rankings

How does Rainbow Child. rank in Healthcare Services?

Compare Rainbow Child. against every Healthcare Services company (Q4 FY23) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Continue your research

What Rainbow Child.'s management said in earlier quarters

Others in Healthcare Services this season

  • Metropolis Healt (Q1 FY27)

    East India currently 6%, with limited investment so far; future investments may increase contribution. Key concall takeaways from Metropolis Healthcare Ltd's…

  • Apollo Hospitals (Q1 FY27)

    IP volume growth for established units guided at roughly 7% to 8%. Key concall takeaways from Apollo Hospitals Enterprise Ltd's Q1 FY27 earnings call — and how…

  • Health X Platform Ltd (Q1 FY27)

    July monthly revenue stood at INR 150+ crores, indicating strong growth momentum. Key concall takeaways from Health X Platform Ltd's Q1 FY27 earnings call…

  • Shalby Ltd (Q1 FY27)

    Shalby MedTech showed strong revenue growth: ₹47 crores in Q1 FY27, a 53% YoY increase. Key concall takeaways from Shalby Ltd's Q1 FY27 earnings call — and how…

Compare:vs Apollo Hospitalsvs Max Healthcare Institute Ltdvs Fortis Health.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →